Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Gage BrodieEVP & Chief Product & |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $390K 1,200 sh | Sep 17, 2026 |
| 14 | Oey Peter HenryChief Financial Officer |  GRABGrab Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $145K 50.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Remer Eric RichardDirector |  EVCMEverCommerce Inc.Open-market sale | SELL | $2,064 258 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Hanson Scott McLeanDirector, Chief Technology Officer |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $300K 4,947 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $519 18 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Jergensen JoshuaPresident & COO |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $153K 3,498 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $50K 800 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Turner Michael S.Chief Legal Officer |  HAWKHawkEye 360, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,250 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $114K 22.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Open-market sale · 10b5-1 plan | SELL | $114K 22.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | McClymont DonaldDirector, Chief Executive Officer |  INDIindie Semiconductor, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 50.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | DiPerna DinoEVP & Chief R&D Officer | CIENCIENA CORP Open-market sale · 10b5-1 plan | SELL | $87K 249 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 11 | DiPerna DinoEVP & Chief R&D Officer | CIENCIENA CORP Open-market sale · 10b5-1 plan | SELL | $81K 249 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Hanson Scott McLeanDirector, Chief Technology Officer | AMBQAmbiq Micro, Inc. Open-market sale · 10b5-1 plan | SELL | $116K 1,953 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 300 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 1,600 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 1,900 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Misra AmitabhChief Technology Officer |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $164K 29.6K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $667K 3,901 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $401K 2,319 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $323K 1,843 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $371K 2,129 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $687K 3,990 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $293K 2,728 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $278K 2,572 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 8 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Fordyce MarshallDirector, PRESIDENT AND CEO |  VERAVera Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $685K 18.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Kenneweg JohnSVP, Sales & Product Marketing |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $54K 5,257 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 8 | Hanson Scott McLeanDirector, Chief Technology Officer | AMBQAmbiq Micro, Inc. Open-market sale · 10b5-1 plan | SELL | $6,100 100 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Tariq MusaDirector | GHGuardant Health, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 116 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $123K 1,214 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $109K 1,100 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $72K 700 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $90K 510 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $223K 1,308 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Kenneweg JohnSVP, Sales & Product Marketing | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $10K 1,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $59K 586 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Open-market sale · 10b5-1 plan | SELL | $382K 75.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $337K 60.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
